Logout Lundbeck sites Contact Us
Cipralex is licenced for the treatment of major depressive disorder (MDD)
To see the efficacy of Cipralex compared to a particular alternative treatment, please select from the options below:
Cipralex treatment demonstrates superior efficacy to duloxetine in the treatment of acute major depressive disorder.
Cipralex (escitalopram) compares favourably to venlafaxine, both in moderate and severely ill depressed patients.
Cipralex is significantly more effective than paroxetine in the long-term treatment of severely depressed patients.
The more severe the depression is in the baseline the greater is the difference in efficacy between Cipralex and its comparators.
Cipralex demonstrates better efficacy, higher rates of response and remission and faster time to symptom relief.
Cipralex presents better efficacy and faster symptom relief